Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03835052 · ClinicalTrials.gov registry record
QOL Assessment in Cancer Survivors Integrated Into Routine Clinical Care
A clinical trial, sponsored by Geisinger Clinic.
- Terminated
- Registry status
- 500
- Enrollment target
NCT03835052: Clinical Trial study, sponsored by Geisinger Clinic.
NCT03835052 is a clinical trial that was terminated before completion, run by Geisinger Clinic. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03835052 was terminated before completion, sponsored by Geisinger Clinic.
- TERMINATED
- Registry status
- 500 participants
- Enrollment target
Study Summary
This observational cohort study of patients who received cancer treatment (of any modality) in the last 18 months are evaluated by the use of a validated QOL tool (FACT-GP) and are evaluated via telephone or in person or both. Patients with high-risk for unmet needs or distress as determined by the FACT-GP are referred to an in-person Multidisciplinary Cancer Survivorship Clinic. This is considered standard of care at the investigator's institution and is part of the continuous clinical quality improvement program within the Geisinger Cancer Institute.
Primary Outcome
A completed Survivorship Care Plan (SCP) as defined by the American College of Surgeons, Committee on Cancer (ACS-CoC) is completed by a member of the clinical care team and is provided personally to the patient.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2020-03-30 |
Why NCT03835052 stopped before completion
NCT03835052 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03835052 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03835052 about?
NCT03835052 is a clinical study titled "QOL Assessment in Cancer Survivors Integrated Into Routine Clinical Care". This observational cohort study of patients who received cancer treatment (of any modality) in the last 18 months are evaluated by the use of a validated QOL tool (FACT-GP) and are evaluated via telephone or in person or both. Patients with high-risk for unmet needs or distress as determined by the ...
What is the current status of trial NCT03835052?
This trial is currently terminated. The enrollment target is 500 participants. The study started on 2018-10-01. Estimated completion is 2020-03-30.
Who is sponsoring clinical trial NCT03835052?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI